TrialJournal of endocrinological investigation2012

Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone.

S Piemonte et al.PubMed ↗Publisher ↗

No numbers read from the abstract.